Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleA phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors.AuthorsBendell, Johanna; Kurkjian, Carla; Infante, Jeffrey; Bauer, Todd; Burris, Howard; Greco, F.; Shih, Kent; Thompson, Dana; Lane, Cassie; Finney, Lindsey; Jones, SuzannePublicationInvestigational New Drugs, 2015, Vol 33, Issue 2, p463ISSN0167-6997Publication typeArticleDOI10.1007/s10637-015-0218-6